SCHEMBL9818448

SCHEMBL9818448

O=C1N(Cl)C(=O)C(c2ccccc2)(c2ccccc2)N1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ELANE P08246 2/20 0.33
ALDH1A1 P00352 2/20 0.33
F2 P00734 1/20 0.33
PLG P00747 1/20 0.33
CTSG P08311 1/20 0.33
CMA1 P23946 1/20 0.33
CTRC Q99895 1/20 0.33
LMNA P02545 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
REN P00797 1/20 0.33
APP P05067 1/20 0.33
BACE1 P56817 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
CYP2C19 P33261 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.32
MEN1 O00255 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358251 0.81 NPSR1 (0.33) PKMNPSR1ELANEALDH1A1F2
SCHEMBL4125062 0.81 NPSR1 (0.33) PKMNPSR1ELANEALDH1A1F2
SCHEMBL10636113 0.81 ELANE (0.36) PKMELANEF2CTSGCMA1
SCHEMBL763669 0.70 PKM (0.38) PKMELANEALDH1A1F2PLG
SCHEMBL5075817 0.69 MMP2 (0.39) PKMNPSR1ALDH1A1LMNATDP1
Iodobenzene SCHEMBL10799601 0.66 ELANE (0.35) NPSR1ELANEALDH1A1CTSG
SCHEMBL17830174 0.64 HTR1A (0.46) PKMALDH1A1LMNARENAPP
SCHEMBL4732888 0.64 PKM (0.34) PKMNPSR1ALDH1A1LMNAREN
SCHEMBL19923635 0.62 ELANE (0.53) NPSR1ELANEF2PLGCTSG
SCHEMBL19923463 0.62 ELANE (0.46) ELANEALDH1A1LMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11905237-B2 Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-02-20 US claimed
CN-109686990-B Preparation method and application of Ni-Zn/nitrogen-sulfur double-doped three-dimensional graphene electrode material 东北大学 2020-11-24 CN claimed
US-20130005786-A1 THERAPEUTIC INVENTION KAPOOR RAJU (GB) 2013-01-03 US claimed
US-12637403-B2 Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation THE CHINESE UNIVERSITY OF HONG KONG (CN) 2026-05-26 US disclosed
EP-3551182-B1 TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING PHENYTOIN AND A (CO -)AN ALGESIC FOR THE TREATMENT OF CHRONIC PAIN TOPICAL INNOVATIONS B V (NL) 2025-03-19 EP disclosed
EP-3551166-B1 TOPICAL PHENYTOIN FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN TOPICAL INNOVATIONS B V (NL) 2024-08-21 EP disclosed
US-20240166586-A1 ACCESS TO CHIRAL BISPHENOL (BPOL) LIGANDS THROUGH DESYMMETRIZING ASYMMETRIC ORTHO-SELECTIVE MONO-HALOGENATION THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-05-23 US disclosed
CN-117886858-A Ammonium phosphate compound and preparation method and application thereof 南昌大学 2024-04-16 CN disclosed
US-11905237-B2 Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-02-20 US disclosed
US-11285099-B2 Topical phenytoin for use in the treatment of peripheral neuropathic pain TOPICAL INNOVATIONS B.V. (NL) 2022-03-29 US disclosed
US-11147799-B2 Topical pharmaceutical composition containing phenytoin and a (co-) analgesic for the treatment of chronic pain Keppel Hesselink, Jan Marius (NL) 2021-10-19 US disclosed
US-20200069649-A1 TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING PHENYTOIN AND A (CO -) ANALGESIC FOR THE TREATMENT OF CHRONIC PAIN TOPICAL INNOVATIONS B.V. (NL) 2020-03-05 US disclosed
EP-3551166-A1 TOPICAL PHENYTOIN FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN TOPICAL INNOVATIONS B.V. (NL) 2019-10-16 EP disclosed
WO-2018106107-A1 TOPICAL PHENYTOIN FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN KOPSKY DAVID JOS (NL) 2018-06-14 WO disclosed
US-20130005786-A1 THERAPEUTIC INVENTION KAPOOR RAJU (GB) 2013-01-03 US disclosed
EP-0177645-B1 PROCESS FOR THE PREPARATION OF HALOGENATED HYDANTOINS LONZA INC. (US) 1991-12-04 EP disclosed
US-4654424-A CONTROLLING PH GLYCO INC. (US) 1987-03-31 US disclosed
US-4560766-A Shaped halogenated hydantoins GLYCO CHEMICALS, INC. (US) 1985-12-24 US disclosed
US-4242518-A Thiophene compounds and their manufacture BASF AKTIENGESELLSCHAFT (DE) 1980-12-30 US disclosed
US-4239897-A Thiophene compounds and their manufacture BASF AKTIENGESELLSCHAFT (DE) 1980-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637403-B2 Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation NR4A1, BRPF3, BPTF PKM 1180/4885NPSR1 443/4885ELANE 2820/4885
US-20240166586-A1 ACCESS TO CHIRAL BISPHENOL (BPOL) LIGANDS THROUGH DESYMMETRIZING ASYMMETRIC ORTHO-SELECTIVE MONO-HALOGENATION OSBP, BICRA, BRPF3 PKM 2824/4885NPSR1 411/4885ELANE 3382/4885
US-20130005786-A1 THERAPEUTIC INVENTION AQP4, PMP22, NHERF1 PKM 1650/4885NPSR1 1940/4885ELANE 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.